Approaching the pruritic patient

Published on 08/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1325 times

Chapter 67 Approaching the pruritic patient

4. What causes an itch?

Itch is mediated by a number of local and central substances. Histamine, produced by skin mast cells, is the classical pruritus mediator. Pricking the skin with histamine produces pruritus in most individuals; however, histamine does not account for all pruritus. Other pruritus mediators include prostaglandin, serotonin, tachykinins, cytokines, and opioid receptors. Prostaglandin E1 lowers the threshold of the skin to itching provoked by histamine. Serotonin, 5-hydroxytryptamine (5-HT), may regulate itch by acting on 5-HT3 receptors. Tachykinins, such as the neuropeptide substance P, cause pruritus for reasons attributable to histamine release from mast cells. Cytokine interleukin-2 may be an important peripheral mediator of itching. Opioid receptors in the central nervous system regulate the intensity and quality of perceived itch.

Understanding pruritus mediators can help classify itch accordingly to origin. The classification of itch includes: a) pruritoceptive—cutaneous nerves are activated by pruritogens at sensory endings, b) neuropathic—diseased or lesion pruritic neurons generate itch, c) neurogenic—itch caused by mediators acting centrally, and d) psychogenic. Although classifications are important, there are limitations as itch can have more than one origin.

Bernard JD, editor: Itch: mechanisms and management of pruritus, New York, 1994, McGraw-Hill.

Buddenkotte J, Steinhoff M: Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy 65:805-821, 2010.

Fazio SB: Pruritus, UpToDate 2000, 2005. Available at: http://www.uptodate.com.

Greaves MW, Wall PD: Pathophysiology of itching, Lancet 348:938–940, 1996.

8. What is notalgia paresthetica?

Notalgia paresthetica is an acquired unilateral localized form of pruritus that develops near the inferomedial border of either scapula. The skin typically appears normal, although some patients demonstrate subtle hyperpigmentation secondary to repeated rubbing or excoriation. The cause is not understood, although there is substantial evidence to suggest that it is due to spinal nerve impingement. Occasional cases have been familial, and the term “hereditary localized pruritus” has been applied to this variant. The management typically consists of topical capsaicin cream or topical preparations containing lidocaine.

Table 67-1. Differential Diagnosis of Localized Pruritus

LOCATION DISEASES
Scalp Psoriasis, seborrheic dermatitis
Trunk Contact dermatitis (axillae, waistline), erythrasma (axillae), psoriasis (periumbilical), notalgia paresthetica, scabies, seborrheic dermatitis, urticaria
Inguinal region Candida, contact dermatitis, erythrasma, overuse of topical steroids, pediculosis, scabies, tinea cruris
Anal region Candida, contact dermatitis, gonorrhea, hemorrhoids, pinworm, psoriasis, tinea cruris
Hands Contact dermatitis, scabies, eczema
Legs Atopic dermatitis (popliteal fossae), dermatitis herpetiformis (knees), lichen simplex chronicus (malleoli), neurotic excoriations, nummular eczema, stasis dermatitis
Feet Contact dermatitis, pitted keratolysis, tinea pedis

Savk O, Savk E: Investigation of spinal pathology in notalgia paresthetica, J Am Acad Dermatol 52:1085–1087, 2005.

9. What is the physician’s best approach when seeing a patient with generalized pruritus?

10. After obtaining a complete history and physical examination, what clinically oriented classification scheme should be followed?

Uremia, cholestasis, primary biliary cirrhosis, chronic renal failure, HIV infection, dermatophysis, drugs, polycythemia rubra vera, Hodgkin’s lymphoma, iron-deficiency anemia, carcinoid syndrome, drug-induced pruritus, solid tumor (such as colon, prostate), perimenopausal pruritus

Multiple sclerosis, neoplasms, cerebral or spinal infarcts, brachioradial pruritus, notalgia paresthetica, postherpetic neuralgia, vulvodynia Depression, anxiety disorders, obsessive-compulsive disorders, schizophrenia    

Diagnostic tests for group I include a skin biopsy and laboratory investigation, such as IgE or indirect immunofluorescence. Diagnostic tests for group II include a laboratory and radiologic investigation based on the patient’s history. Diagnostic tests for group III include a skin biopsy and laboratory and radiologic investigation based on patient’s history.

Initial tests include

21. What are the common causes of cholestic pruritus?

The three most common causes of cholestic pruritus are primary biliary cirrhosis, cholestasis of pregnancy, and cholestasis from drugs. Pruritus affects virtually 100% of all patients with primary biliary cirrhosis (PBC) and is the initial symptom in 50%. PBC is a disease of unknown etiology characterized by the destruction of small intrahepatic bile ducts by a granulomatous reaction. Approximately 90% of the patients are female. The serum antimitochondrial antibody test against M2, a component of the pyruvate dehydrogenase complex of mitochondrial enzymes, is 88% sensitive and 96% specific for PBC. Treatment is hepatic transplantation, and it completely eliminates the pruritus. Benign cholestatic jaundice of pregnancy is a frequent cause of pruritus in pregnancy. The pruritus is most severe in the third trimester. The pruritus disappears and elevated liver function tests return to normal after delivery. Pruritus secondary to cholestasis frequently occurs with drug therapy. Common culprits include oral contraceptives, anabolic steroids, cephalosporins, chlorpropamide, cimetidine, erythromycin estolate, gold, nonsteroidal antiinflammatory drugs, nicotinic acid, penicillin, phenothiazine, phenytoin, progestin, and tolbutamide. Removal of the offending drug usually leads to resolution of symptoms. Other causes of cholestatic pruritus include primary sclerosing cholangitis, obstructive choledocholithiasis, carcinoma blocking the biliary tree, or chronic hepatitis C.

Mela M, Mancuso A, Burroughs AK: Review article: pruritus in cholestatic and other liver diseases, Aliment Pharmacol Ther 17:857–870, 2003.

25. What is the best symptomatic treatment for a patient with pruritus?

The best treatment for a patient with pruritus involves identifying an underlying dermatosis or systemic disorder responsible for the pruritus and treating that disease. All patients should be advised about appropriate skin care, which includes adequate nutrition and daily fluid intake, protection from the environment, and cleansing practices that do not dry the skin. In addition to the skin care factors, medications applied to the skin or taken by mouth may be necessary to treat pruritus. Topical agents containing menthol produce a cooling sensation. Topical agents containing phenol or camphor have local anesthetic effects. Pramoxine, another topical anesthetic, can provide relief. If appropriate, topical corticosteroids can be used for local control. Oral antihistamines, such as hydroxyzine or doxepin, are commonly used and often provide the first-line treatment for pruritus with no identifiable cause. Other less traditional therapies and techniques are reserved for refractory cases and are best reserved for the practicing clinical dermatologist to address (Table 67-3).

Table 67-3. Treatment of Pruritus

Topical Cooling agents, emollients, topical corticosteroids, anesthetics
Systemic Antihistamines, systemic corticosteroids, opioid receptor antagonists
Phototherapy Ultraviolet B (UVB), narrowband UVB (NBUVB)
Miscellaneous Transcutaneous electrical nerve stimulation (TENS), acupuncture, capsaicin

All patients should be advised regarding the avoidance of scratching to focus on interrupting the itch-scratch-itch cycle. Breaking the itch-scratch-itch cycle (an increase in itching that can result from the process of scratching) may also help to alleviate pruritus. The cycle may be broken by applying a cool washcloth or ice over the affected area.

Greece PJ, Ende J: Pruritus: a practical approach, J Gen Intern Med 7:340–349, 1992.